Clinical Trials in Attiki, Greece
4 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Immunovant Sciences GmbH56 enrolled85 locationsNCT06980805
Recruiting
Not Applicable
Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.
Infection, BacterialInfection Prevention
PENTA Foundation3,080 enrolled24 locationsNCT05993442
Recruiting
Phase 2
A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.
Multiple Myeloma, Refractory
Karyopharm Therapeutics Inc127 enrolled16 locationsNCT04414475
Recruiting
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
Aneurysm ThoracicDissection of Thoracic Aorta
Lifetech Scientific (Shenzhen) Co., Ltd.145 enrolled8 locationsNCT05639569
Recruiting
Phase 1Phase 2
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Rhabdomyosarcoma
University of Birmingham1,672 enrolled128 locationsNCT04625907